Norges Bank’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $299K | Buy |
+13,766
| New | +$299K | ﹤0.01% | 1669 |
|
|
2025
Q1 | – | Sell |
-91,770
| Closed | -$1.92M | – | 393 |
|
|
2024
Q4 | $1.92M | Buy |
+91,770
| New | +$1.92M | ﹤0.01% | 1693 |
|
|
2024
Q2 | – | Sell |
-120,000
| Closed | -$1.91M | – | 1949 |
|
|
2024
Q1 | $1.91M | Buy |
+120,000
| New | +$1.91M | ﹤0.01% | 1740 |
|
|
2023
Q1 | – | Sell |
-314,400
| Closed | -$5.85M | – | 2105 |
|
|
2022
Q4 | $5.85M | Sell |
314,400
-577,400
| -65% | -$10.7M | ﹤0.01% | 1731 |
|
|
2022
Q3 | $11.4M | Buy |
+891,800
| New | +$11.4M | ﹤0.01% | 1479 |
|